Evidence map›Paper›PMID 30506286›Full record

ArticleMycopathologia2018

Eighty Years of Mycopathologia: A Retrospective Analysis of Progress Made in Understanding Human and Animal Fungal Pathogens.

Vishnu Chaturvedi, Jean-Philippe Bouchara, Ferry Hagen, Ana Alastruey-Izquierdo, Hamid Badali, Anamelia Lorenzetti Bocca, Jose F Cano-Lira, Cunwei Cao, Sudha Chaturvedi, Sanjay H Chotirmall and 20 more

Open access · bronzeAbstract readEditorialHistorical Article
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The Emericellipsins A-E from an Alkalophilic FungusJournal of fungi (Basel, Switzerland) · 2021
    Article
  5. Evaluation of the chemical constituents and potential biological activities ofSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 20 institutions in 13 countries.

Vishnu ChaturvediNew York State Department of Health and University at Albany, Albany, NY, USA. eic@mycopathologia.net.
Jean-Philippe BoucharaUniversité Bretagne-Loire, Angers, France.
Ferry HagenWesterdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.
Ana Alastruey-IzquierdoInstituto Salud Carlos III, Madrid, Spain.
Hamid BadaliMazandaran University of Medical Sciences, Sari, Iran.
Anamelia Lorenzetti BoccaUniversity of Brasilia (UnB), Brasíla, DF, Brazil.
Jose F Cano-LiraUniversitat Rovira i Virgili, Reus, Spain.
Cunwei CaoGuangxi Medical University, Nanning, China.
Sudha ChaturvediNew York State Department of Health and University at Albany, Albany, NY, USA.
Sanjay H ChotirmallLee Kong Chian School of Medicine, Singapore, Singapore.
Anne D van DiepeningenWageningen University and Research, Wageningen, The Netherlands.
Jean-Pierre GangneuxUniversité Rennes, Rennes, France.
Jesus GuineaUniversidad Complutense, Madrid, Spain.
Sybren de HoogWesterdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.
Macit IlkitUniversity of Çukurova, Adana, Turkey.
Rui KanoNihon University College of Bioresource Sciences, Fujisawa, Japan.
Weida LiuPeking Union Medical College, Nanjing, China.
Nilce M Martinez-RossiRibeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
Marcia de Souza Carvalho MelhemAdolfo Lutz Institute, São Paulo, Brazil.
Mario Augusto OnoState University of Londrina, Londrina, Brazil.
Yuping RanSichuan University, Chengdu, China.
Stephane RanqueUniversité Aix-Marseille, Marseille, France.
Celia Maria de Almeida SoaresUniversidade Federal de Goiás, Goiânia, Goiás, Brazil.
Takashi SugitaMeiji Pharmaceutical University, Tokyo, Japan.
Philip A ThomasInstitute of Ophthalmology, Joseph Eye Hospital, Tiruchirappalli, India.
Anna VecchiarelliUniversità di Perugia, Perugia, Italy.
Nancy L WengenackMayo Clinic, Rochester, MN, USA.
Patrick C Y WooThe University of Hong Kong, Pokfulam, Hong Kong.
Jianping XuMcMaster University, Hamilton, ON, Canada.
Rosely M Zancope-OliveiraFundação Oswaldo Cruz, Rio de Janeiro, Brazil.
University at Albany, State University of New York · USWesterdijk Fungal Biodiversity Institute · NLAix-Marseille Université · FRCukurova University · TREscuela Nacional de Sanidad · ESFundação Oswaldo Cruz · BRGuangxi Medical University · CNInstituto Adolfo Lutz · BRJoseph Eye Hospital · INMayo Clinic in Arizona · USMazandaran University of Medical Sciences · IRMcMaster University · CAMeiji Pharmaceutical University · JPNihon University · JPPeking Union Medical College Hospital · CNSichuan University · CNUniversidad Complutense de Madrid · ESUniversidade de Brasília · BRUniversidade de São Paulo · BRUniversidade Estadual de Londrina · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycopathologia was founded in 1938 to 'diffuse the understanding of fungal diseases in man and animals among mycologists.' This was an important mission considering that pathogenic fungi for humans and animals represent a tiny minority of the estimated 1.5-5 million fungal inhabitants on Earth. These pathogens have diverged from the usual saprotrophic lifestyles of most fungi to colonize and infect humans and animals. Medical and veterinary mycology is the subdiscipline of microbiology that dwells into the mysteries of parasitic, fungal lifestyles. Among the oldest continuing scientific publications on the subject, Mycopathologia had its share of 'classic papers' since the first issue was published in 1938. An analysis of the eight decades of notable contributions reveals many facets of host-pathogen interactions among 183 volumes comprising about 6885 articles. We have analyzed the impact and relevance of this body of work using a combination of citation tools (Google Scholar and Scopus) since no single citation metric gives an inclusive perspective. Among the highly cited Mycopathologia publications, those on experimental mycology accounted for the major part of the articles (36%), followed by diagnostic mycology (16%), ecology and epidemiology (15%), clinical mycology (14%), taxonomy and classification (10%), and veterinary mycology (9%). The first classic publication, collecting nearly 200 citations, appeared in 1957, while two articles published in 2010 received nearly 150 citations each, which is notable for a journal covering a highly specialized field of study. An empirical analysis of the publication trends suggests continuing interests in novel diagnostics, fungal pathogenesis, review of clinical diseases especially with relevance to the laboratory scientists, taxonomy and classification of fungal pathogens, fungal infections and carriage in pets and wildlife, and changing ecology and epidemiology of fungal diseases around the globe. We anticipate that emerging and re-emerging fungal pathogens will continue to cause significant health burden in the coming decades. It remains vital that scientists and physicians continue to collaborate by learning each other's language for the study of fungal diseases, and Mycopathologia will strive to be their partner in this increasingly important endeavor to its 100th anniversary in 2038 and beyond.

Indexed as

BibliometricsHost-Pathogen InteractionsPeriodicals as TopicAnimalsFungiHistory, 20th CenturyHistory, 21st CenturyHumansMycologyMycosesRetrospective Studies

Identifiers

PMID30506286
OpenAlexW2903111832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.